Showing 18 of 18 recruiting trials for “vulvar-adenocarcinoma”
Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda
AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
👨⚕️ Jeremie Calais, UCLA / Jonsson Comprehensive Cancer Center📍 1 site📅 Started Aug 2025View details ↗
RecruitingNCT07100288 ↗
Anatomopathological Analysis of the Infundibulopelvic Ligament in Patients With Ovarian Cancer
🏥 Complejo Hospitalario Universitario Insular Materno Infantil📍 1 site📅 Started Jul 2025View details ↗
A Study of Lorigerlimab in Participants With Advanced Solid Tumors
IN10018 With Nab-Paclitaxel and Cadonilimab for Metastatic or Recurrent Gastric-Type Cervical Adenocarcinoma: Phase 2 Trial
👨⚕️ Peng Wu, Ph.D, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China📍 2 sites📅 Started Feb 2025View details ↗
Ivonescimab in the Treatment of Multiple Advanced Tumors
Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring
PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer
Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic Cancer
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
Letrozole for Estrogen/Progesterone Receptor Positive Low-grade Serous Epithelial Ovarian Cancer (LEPRE Trial)
RecruitingNCT05461430 ↗
Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
👨⚕️ Andrea B Apolo, Alliance for Clinical Trials in Oncology📍 580 sites📅 Started May 2019View details ↗
RecruitingNCT03452774 ↗
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →